Ria Health Raises Growth Capital to Accelerate Access to Patient-Driven AUD Treatment
2024 SV Therapeutics Impact & ESG Report
Read More
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
Read More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
- 16 December 2019Portfolio NewsDeciphera Pharmaceuticals Announces Submission of New Drug Application to U.S. FDA for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
2 December 2019Portfolio NewsBardy Diagnostics™ Wins the Remote Monitoring in Arrhythmias Digital Health Pitch Session at European Society of Cardiology Congress 2019 and Presents at UK Heart Rhythm Congress 2019
18 November 2019Portfolio NewsEBT Secures USD$10M Series A
7 November 2019Portfolio NewsAmerican Well® Acquires Aligned Telehealth to Expand Behavioral Health Virtual Care
6 November 2019Portfolio NewsArtios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
5 November 2019Portfolio NewsHealthify Raises $16M to Integrate Health and Social Services
23 October 2019Portfolio NewsClarify Medical Closes $18M Series A Round to Commercialize its Connected Home Phototherapy System in the US
21 October 2019Portfolio NewsSkyKnight Capital Invests in Home Healthcare Leader AeroCare- 10 October 2019Portfolio NewsRheostat Therapeutics Announces Rebrand to Caraway Therapeutics and New Kendall Square Office
10 October 2019SV NewsDDF hosts Second Annual Forum to review progress in novel dementia therapeutics
8 October 2019Portfolio NewsAVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
1 October 2019Portfolio NewsEndotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution
